Search details
1.
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer.
Breast Cancer Res
; 26(1): 32, 2024 02 26.
Article
in English
| MEDLINE | ID: mdl-38408999
2.
Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection.
Proc Natl Acad Sci U S A
; 118(23)2021 06 08.
Article
in English
| MEDLINE | ID: mdl-34078669
3.
A generalized covariate-adjusted top-scoring pair algorithm with applications to diabetic kidney disease stage classification in the Chronic Renal Insufficiency Cohort (CRIC) Study.
BMC Bioinformatics
; 24(1): 57, 2023 Feb 20.
Article
in English
| MEDLINE | ID: mdl-36803209
4.
Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy.
Clin Gastroenterol Hepatol
; 21(7): 1924-1936.e9, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36270618
5.
Declines in cigarette smoking among US adolescents and young adults: indications of independence from e-cigarette vaping surge.
Tob Control
; 2023 Nov 08.
Article
in English
| MEDLINE | ID: mdl-37940404
6.
Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017-2019.
Tob Control
; 32(e2): e145-e152, 2023 08.
Article
in English
| MEDLINE | ID: mdl-35131948
7.
Patient Blood Type Is Associated With Response to Immune Checkpoint Blockade in Metastatic Cancer.
Oncologist
; 27(9): e739-e747, 2022 09 02.
Article
in English
| MEDLINE | ID: mdl-35816018
8.
PI3KĆĀ³ is a molecular switch that controls immune suppression.
Nature
; 539(7629): 437-442, 2016 11 17.
Article
in English
| MEDLINE | ID: mdl-27642729
9.
Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody.
Proc Natl Acad Sci U S A
; 116(4): 1370-1377, 2019 01 22.
Article
in English
| MEDLINE | ID: mdl-30622177
10.
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial.
Lancet Oncol
; 22(6): 883-892, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33989559
11.
Cirmtuzumab blocks Wnt5a/ROR1 stimulation of NF-κB to repress autocrine STAT3 activation in chronic lymphocytic leukemia.
Blood
; 134(13): 1084-1094, 2019 09 26.
Article
in English
| MEDLINE | ID: mdl-31409670
12.
Racial/Ethnic Disparities Across Indicators of Cigarette Smoking in the Era of Increased Tobacco Control, 1992-2019.
Nicotine Tob Res
; 23(6): 909-919, 2021 05 24.
Article
in English
| MEDLINE | ID: mdl-33196799
13.
A strategy for validation of variables derived from large-scale electronic health record data.
J Biomed Inform
; 121: 103879, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34329789
14.
Tool to assess appeal-aversion response to graphic warning labels on cigarette packs among US smokers.
Tob Control
; 30(3): 312-319, 2021 05.
Article
in English
| MEDLINE | ID: mdl-32345609
15.
Use of Electronic Cigarettes to Aid Long-Term Smoking Cessation in the United States: Prospective Evidence From the PATH Cohort Study.
Am J Epidemiol
; 189(12): 1529-1537, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-32715314
16.
Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways.
Br J Cancer
; 123(4): 568-579, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32457362
17.
Research-based PAM50 signature and long-term breast cancer survival.
Breast Cancer Res Treat
; 179(1): 197-206, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31542876
18.
Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer.
J Transl Med
; 18(1): 214, 2020 05 28.
Article
in English
| MEDLINE | ID: mdl-32466781
19.
Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer.
Breast Cancer Res
; 26(1): 46, 2024 Mar 13.
Article
in English
| MEDLINE | ID: mdl-38481291
20.
Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
J Virol
; 91(19)2017 10 01.
Article
in English
| MEDLINE | ID: mdl-28724768